This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 24-30 January 2026 and includes updates on respiratory virus epidemiology in the EU/EEA, Marburg virus disease, cholera, avian influenza, bacillus in infant formula, and nipah virus disease.
Respiratory virus circulation is elevated across the EU/EEA: the circulation of influenza viruses remains high with early signs of a new increase, RSV circulation is elevated and increasing, and SARS-CoV-2 circulation remains at low levels.
This e-learning course aims at increasing understanding of the drivers and barriers of vaccine acceptance. You will learn how to design targeted strategies to increase vaccine uptake through behaviour change.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 17-23 January 2026 and includes updates on respiratory virus epidemiology in the EU/EEA, avian influenza, and Marburg virus disease.
Respiratory virus circulation is elevated across the EU/EEA: circulation of influenza viruses is high, but has peaked; RSV circulation is elevated and increasing, and SARS-CoV-2 circulation remains at low levels.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 10-16 January 2026 and includes updates on respiratory virus epidemiology in the EU/EEA, measles, mpox, and Marburg virus disease.
Respiratory virus circulation is elevated across the EU/EEA: circulation of influenza viruses is high but has peaked, RSV circulation is elevated and increasing and SARS-CoV-2 circulation remains at low levels.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 3-9 January 2026 and includes updates on respiratory virus epidemiology, cholera, Marburg virus, Middle East respiratory syndrome coronavirus (MERS-CoV), avian influenza, and swine influenza.
Respiratory viruses are on the rise across the EU/EEA: circulation of influenza viruses and RSV is increasing in several countries, while SARS-CoV-2 circulation continues to decrease